Nathanael G. Bailey, M.D.

  1. Hematopathologist
  1. Baloda V, Al Amri R, Patwardhan PP, Monaghan SA, Moore EM, Rea B, Djokic M, Aggarwal N, Bullock GC, Liu YC, Yatsenko S, Bailey NG. Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic Features. Mod Pathol. 2025 Oct; 38 (10):100823 Epub 2025 June 18
    View PubMed
  2. Patwardhan PP, Al Amri RD, Baloda V, Aarabi M, Aggarwal N, Djokic M, Monaghan SA, Moore EM, Rea B, Bailey NG. Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort. J Hematop. 2025 Sep 12; 18 (1):42 Epub 2025 Sept 12
    View PubMed
  3. Daley JD, Mukherjee E, Ferraro D, Tufino AC, Bailey N, Bhaskar S, Periyapatna N, MacFawn I, Hartwick S, Kunning S, Hinck C, Bruno TC, Olson AC, McAllister-Lucas LM, Hinck AP, Cooper K, Bao R, Cillo AR, Bailey KM. TGFbeta inhibition during radiation therapy enhances immune cell infiltration and decreases metastases in Ewing sarcoma. Cancer Res Commun. 2025 Aug 8 Epub 2025 Aug 08
    View PubMed
  4. Molina LM, Bailey N, Jawad M, Patwardhan PP, Friehling E, Bailey K, Windreich RM, Al-Attar A, Davis K, Gestrich CK. A Rare Case of Concurrent Neuroblastoma and Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion: A Diagnostic and Therapeutic Dilemma. Pediatr Blood Cancer 2025 Aug; 72 (8):e31815 Epub 2025 May 19
    View PubMed
  5. Patwardhan PP, Al-Attar A, Aggarwal N, Bailey NG, Davis K, Jawad M, Monaghan SA, Rea B, Moore EM. The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas. Am J Surg Pathol. 2025 Jul 23 Epub 2025 July 23
    View PubMed
  6. Patwardhan PP, Baloda V, Al Amri RD, Aarabi M, Bailey NG. Variant allele fraction or copy-neutral loss of heterozygosity? A comparison of testing platforms in the classification of myeloid neoplasia. J Hematop. 2025 Apr 23; 18 (1):21
    View PubMed
  7. Patwardhan PP, Baloda V, Al Amri RD, Aarabi M, Bailey NG. Variant allele fraction or copy-neutral loss of heterozygosity? A comparison of testing platforms in the classification of myeloid neoplasia. J Hematop. 2025 Apr 23; 18(1):21.
    View PubMed
  8. Sahasrabuddhe AA, Chen X, Ma K, Wu R, Liang HC, Kapoor R, Chhipa RR, Onder O, McFetridge C, Van Arnam JS, Zhang X, Morrissette JJD, Pillai V, Li MM, Szankasi P, Basrur V, Conlon KP, Raabe TD, Bailey NG, Hogaboam CM, Rottapel R, Kim J, López C, Schlesner M, Siebert R, Dreval K, Morin RD, Moro L, Pagano M, Staudt LM, Lim MS, Elenitoba-Johnson KSJ. The FBXO45-GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis. Cancer Discov. 2025 Apr 02; 15(4):838-861.
    View PubMed
  9. Patwardhan PP, Bailey NG, Monaghan SA, Singhi AD, Aggarwal N, Djokic M, Moore EM, Rea B. IRF8 Demonstrates Positivity in a Significant Subset of Histiocytic and Dendritic Cell Neoplasms. Am J Surg Pathol. 2025 Feb 01; 49(2):98-103. Epub 2024 Nov 21.
    View PubMed
  10. Weiss J, Gibbons K, Ehyaee V, Perez-Silos V, Zevallos A, Maienschein-Cline M, Brister E, Sverdlov M, Shah E, Balakrishna J, Symes E, Frederiksen JK, Gann PH, Post R, Lopez-Hisijos N, Reneau J, Venkataraman G, Bailey N, Brown NA, Xu ML, Wilcox RA, Inamdar K, Murga-Zamalloa C. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program. Am J Pathol. 2024 Jan; 194(1):165-178. Epub 2023 Nov 03.
    View PubMed
  11. Chopra S, Bailey NG. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms. Am J Clin Pathol. 2023 Dec 01; 160(6):566-570.
    View PubMed
  12. Alsouqi A, Kleinberger J, Werner TS, Awan R, Chopra S, Rea B, Aggarwal N, Yatsenko SA, Farah R, Bailey NG. Novel FIP1L1::KIT fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response. Haematologica. 2023 Nov 1; 108 (11):3181-3185 Epub 2023 Nov 01
    View PubMed
  13. Davis AR, Canady BC, Aggarwal N, Bailey NG. Clinicopathologic Features of IDH2 R172-Mutated Myeloid Neoplasms. Am J Clin Pathol. 2023 Jul 05; 160(1):89-97.
    View PubMed
  14. Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Boyiadzis M, Bailey NG. Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy. Leuk Lymphoma. 2023 Mar; 64(3):750-752. Epub 2023 Feb 01.
    View PubMed
  15. Cillo AR, Mukherjee E, Bailey NG, Onkar S, Daley J, Salgado C, Li X, Liu D, Ranganathan S, Burgess M, Sembrat J, Weiss K, Watters R, Bruno TC, Vignali DAA, Bailey KM. Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks. Clin Cancer Res. 2022 Nov 14; 28(22):4968-4982.
    View PubMed
  16. Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J, Sverdlov M, Wolfe A, Brown N, Harms P, Bailey NG, Inamdar K, Hristov AC, Tejasvi T, Montes J, Barrionuevo C, Taxa L, Casavilca S, de Pádua Covas Lage JLA, Culler HF, Pereira J, Runge JS, Qin T, Tsoi LC, Hong HS, Zhang L, Lyssiotis CA, Ohe R, Toubai T, Zevallos-Morales A, Murga-Zamalloa C, Wilcox RA. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood Cancer J. 2022 Nov 04; 12(11):149.
    View PubMed
  17. Gao X, Wang C, Abdelrahman S, Kady N, Murga-Zamalloa C, Gann P, Sverdlov M, Wolfe A, Polk A, Brown N, Bailey NG, Inamdar K, Casavilca-Zambrano S, Montes J, Barrionuevo C, Taxa L, Reneau J, Siebel CW, Maillard I, Wilcox RA. Notch Signaling Promotes Mature T-Cell Lymphomagenesis. Cancer Res. 2022 Oct 17; 82(20):3763-3773.
    View PubMed
  18. Hegazy SE, Bailey NG. Progression of CCND1- in situ mantle cell neoplasia to CCND1- mantle cell lymphoma. Blood. 2022 Sep 8; 140 (10):1182
    View PubMed
  19. Baloda V, Wheeler SE, Murray DL, Kohlhagen MC, Vos JA, Yatsenko SA, Agha ME, Djokic M, Swerdlow SH, Bailey NG. Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma. Diagn Pathol. 2022 Aug 05; 17(1):63.
    View PubMed
  20. Maurer LM, Daley JD, Mukherjee E, Venier RE, Julian CM, Bailey NG, Jacobs MF, Kumar-Sinha C, Raphael H, Periyapatna N, Weiss K, Janeway KA, Mody R, Lucas PC, McAllister-Lucas LM, Bailey KM. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma. Cancer Res Commun. 2022 Apr; 2 (4):220-232 Epub 2022 Apr 20
    View PubMed
  21. Maurer LM, Daley JD, Mukherjee E, Venier RE, Julian CM, Bailey NG, Jacobs MF, Kumar-Sinha C, Raphael H, Periyapatna N, Weiss K, Janeway KA, Mody R, Lucas PC, McAllister-Lucas LM, Bailey KM. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma. Cancer Res Commun. 2022 Apr; 2 (4):220-232 Epub 2022 Apr 20
    View PubMed
  22. Bailey NG. Visualization of the Effect of Assay Size on the Error Profile of Tumor Mutational Burden Measurement. Genes (Basel). 2022 Feb 26; 13(3).
    View PubMed
  23. Martinez RJ, Kang Q, Nennig D, Bailey NG, Brown NA, Betz BL, Tewari M, Thyagarajan B, Bachanova V, Mroz P. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia. Arch Pathol Lab Med. 2022 Jan 01; 146(1):92-100.
    View PubMed
  24. Anekpuritanang T, Klairmont MM, Gradowski J, Hagiwara K, Bailey NG, Chandra P, Liu Y, Mulder HL, Easton J, Zhang J, Martin MG, Owczarczyk AB, Dunlap JB, Fan G, Press RD, Raess PW. In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood Adv. 2021 Dec 14; 5 (23):5057-5059
    View PubMed
  25. Yerneni SS, Werner S, Azambuja JH, Ludwig N, Eutsey R, Aggarwal SD, Lucas PC, Bailey N, Whiteside TL, Campbell PG, Hiller NL. Pneumococcal Extracellular Vesicles Modulate Host Immunity. mBio. 2021 Aug 31; 12 (4):e0165721 Epub 2021 July 13
    View PubMed
  26. Carlsen E, Bailey NG, Aggarwal N, Illar GM, Wild M, Yatsenko SA, Rea B, Liu YC. Clinicopathologic Characterization of Hypocellular Acute Myeloid Leukemia (AML) Showed Fewer Genetic Abnormalities Involving Cell Proliferation and NPM1 When Compared With Nonhypocellular AML. Am J Clin Pathol. 2021 Feb 11; 155 (3):446-454
    View PubMed
  27. Bailey. Molecular methods for measurable residual disease in acute myeloid leukemia: where are we and where are we going? J Hematopathol. 2021.
  28. Barasch NJK, Liu YC, Ho J, Bailey N, Aggarwal N, Cook JR, Swerdlow SH. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. Hum Pathol. 2020 Dec; 106:93-105. Epub 2020 Oct 09.
    View PubMed
  29. Bailey NG, Elenitoba-Johnson KSJ. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas. Cold Spring Harb Perspect Med. 2020 Nov 2; 10 (11) Epub 2020 Nov 02
    View PubMed
  30. Liu YC, Illar GM, Bailey NG. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. J Clin Pathol. 2020 Nov; 73(11):728-736. Epub 2020 Mar 26.
    View PubMed
  31. Rea B, Bailey NG. Acute myeloid leukaemia with t(8;16)(p11.2;p13.3) and erythrophagocytosis. Br J Haematol. 2020 Jul; 190 (2):133 Epub 2020 Apr 08
    View PubMed
  32. Rea B, Aggarwal N, Yatsenko SA, Bailey N, Liu YC. Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q). Mod Pathol. 2020 Apr; 33(4):566-575. Epub 2019 Nov 04.
    View PubMed
  33. Murga-Zamalloa C, Rolland DCM, Polk A, Wolfe A, Dewar H, Chowdhury P, Onder O, Dewar R, Brown NA, Bailey NG, Inamdar K, Lim MS, Elenitoba-Johnson KSJ, Wilcox RA. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. Clin Cancer Res. 2020 Feb 1; 26 (3):690-703 Epub 2019 Oct 21
    View PubMed
  34. Bailey NG, Elenitoba-Johnson KSJ. What is new in mature T-cell leukemias? Semin Diagn Pathol. 2020 Jan; 37 (1):72-78 Epub 2019 Dec 17
    View PubMed
  35. Lim MS, Bailey NG, King RL, Piris M. Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms. Am J Clin Pathol. 2019 Aug 01; 152(3):277-301.
    View PubMed
  36. Perry AM, Bailey NG, Bonnett M, Jaffe ES, Chan WC. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract. Int J Surg Pathol. 2019 Feb; 27 (1):102-107 Epub 2018 July 09
    View PubMed
  37. Bailey,, Lopez,. Soft Tissue Fibroblastic Reticular Cell Tumor With Whole-Exome Sequencing Findings: An Unexpected Presentation of Lynch Syndrome. AJSP: Reviews & Reports. 2019; 24(6):288-291.
  38. Jin X, Qin T, Zhao M, Bailey N, Liu L, Yang K, Ng V, Higashimoto T, Coolon R, Ney G, Figueroa ME, Li Q. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells. Blood Adv. 2018 Jun 12; 2(11):1259-1271.
    View PubMed
  39. Zhang JY, Briski R, Devata S, Kaminski MS, Phillips TJ, Mayer TL, Bailey NG, Wilcox RA. Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL). Am J Hematol. 2018 Mar; 93(3):394-400. Epub 2017 Dec 18.
    View PubMed
  40. Murga-Zamalloa C, Polk A, Hanel W, Chowdhury P, Brown N, Hristov AC, Bailey NG, Wang T, Phillips T, Devata S, Poonnen P, Gomez-Gelvez J, Inamdar KV, Wilcox R. Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas. Oncotarget. 2017 Dec 6; 8(70):114474–114480.
    View PubMed
  41. Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminski MS, Phillips T, Devata S, Mayer T, Wilcox RA. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. Am J Hematol. 2017 Dec; 92 (12):1287-1294 Epub 2017 Sept 25
    View PubMed
  42. Rolland DCM, Basrur V, Jeon YK, McNeil-Schwalm C, Fermin D, Conlon KP, Zhou Y, Ng SY, Tsou CC, Brown NA, Thomas DG, Bailey NG, Omenn GS, Nesvizhskii AI, Root DE, Weinstock DM, Faryabi RB, Lim MS, Elenitoba-Johnson KSJ. Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas. Proc Natl Acad Sci U S A. 2017 Jun 20; 114 (25):6581-6586 Epub 2017 June 12
    View PubMed
  43. Wang T, Lu Y, Polk A, Chowdhury P, Murga-Zamalloa C, Fujiwara H, Suemori K, Beyersdorf N, Hristov AC, Lim MS, Bailey NG, Wilcox RA. T-cell Receptor Signaling Activates an ITK/NF-kappaB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. Clin Cancer Res. 2017 May 15; 23 (10):2506-2515 Epub 2016 Oct 25
    View PubMed
  44. Tasian SK, Hurtz C, Wertheim GB, Bailey NG, Lim MS, Harvey RC, Chen IM, Willman CL, Astles R, Zebrowski A, Reshmi SC, Li MM, Frey NV, Luger SM, Carroll M, Perl AE. High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL. Leukemia. 2017 Apr; 31 (4):981-984 Epub 2016 Dec 09
    View PubMed
  45. Polk A, Lu Y, Wang T, Seymour E, Bailey NG, Singer JW, Boonstra PS, Lim MS, Malek S, Wilcox RA. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. Clin Cancer Res. 2016 Dec 15; 22 (24):6118-6128 Epub 2016 June 22
    View PubMed
  46. Behdad A, Bailey NG. Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas. Surg Pathol Clin. 2016 Mar; 9 (1):41-54
    View PubMed
  47. Weyand AC, Yanik GA, Bailey NG, Wu YM, Mody RJ, Castle VP. Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome. Pediatr Blood Cancer. 2016 Jan; 63 (1):164-7 Epub 2015 Aug 08
    View PubMed
  48. Bailey NG, Elenitoba-Johnson KS. Mature T-cell leukemias: Molecular and Clinical Aspects. Curr Hematol Malig Rep. 2015 Dec; 10 (4):421-8
    View PubMed
  49. Wang ML, Bailey NG. Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy. Arch Pathol Lab Med. 2015 Oct; 139 (10):1215-23
    View PubMed
  50. Kiel MJ, Sahasrabuddhe AA, Rolland DCM, Velusamy T, Chung F, Schaller M, Bailey NG, Betz BL, Miranda RN, Porcu P, Byrd JC, Medeiros LJ, Kunkel SL, Bahler DW, Lim MS, Elenitoba-Johnson KSJ. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome. Nat Commun. 2015 Sep 29; 6:8470 Epub 2015 Sept 29
    View PubMed
  51. Brown NA, Weigelin HC, Bailey N, Laliberte J, Elenitoba-Johnson KS, Lim MS, Betz BL. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays. Appl Immunohistochem Mol Morphol. 2015 Sep; 23 (8):590-600
    View PubMed
  52. Joseph JR, Wilkinson DA, Bailey NG, Lieberman AP, Tsien CI, Orringer DA. Aggressive Myeloid Sarcoma Causing Recurrent Spinal Cord Compression. World Neurosurg. 2015 Sep; 84 (3):866.e7-10 Epub 2015 Apr 15
    View PubMed
  53. Briski R, Feldman AL, Bailey NG, Lim MS, Ristow K, Habermann TM, Macon WR, Inwards DJ, Colgan JP, Nowakowski GS, Kaminski MS, Witzig TE, Ansell SM, Wilcox RA. Survival in patients with limited-stage peripheral T-cell lymphomas. Leuk Lymphoma. 2015 Jun; 56(6):1665-70. Epub 2014 Oct 30.
    View PubMed
  54. Nie Z, Du MQ, McAllister-Lucas LM, Lucas PC, Bailey NG, Hogaboam CM, Lim MS, Elenitoba-Johnson KS. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma. Nat Commun. 2015 Jan 08; 6:5908.
    View PubMed
  55. Brown NA, Betz BL, Weigelin HC, Elenitoba-Johnson KS, Lim MS, Bailey NG. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia. Am J Clin Pathol. 2015 Jan; 143 (1):89-99
    View PubMed
  56. Velusamy T, Kiel MJ, Sahasrabuddhe AA, Rolland D, Dixon CA, Bailey NG, Betz BL, Brown NA, Hristov AC, Wilcox RA, Miranda RN, Medeiros LJ, Jeon YK, Inamdar KV, Lim MS, Elenitoba-Johnson KS. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders. Blood. 2014 Dec 11; 124 (25):3768-71 Epub 2014 Oct 27
    View PubMed
  57. Behdad A, Bailey NG. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings. Arch Pathol Lab Med. 2014 Oct; 138 (10):1295-301
    View PubMed
  58. Kiel MJ, Velusamy T, Rolland D, Sahasrabuddhe AA, Chung F, Bailey NG, Schrader A, Li B, Li JZ, Ozel AB, Betz BL, Miranda RN, Medeiros LJ, Zhao L, Herling M, Lim MS, Elenitoba-Johnson KS. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood. 2014 Aug 28; 124 (9):1460-72 Epub 2014 May 13
    View PubMed
  59. Briski R, Feldman AL, Bailey NG, Lim MS, Ristow K, Habermann TM, Macon WR, Inwards DJ, Colgan JP, Nowakowski GS, Kaminski MS, Witzig TE, Ansell SM, Wilcox RA. The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas. Blood Cancer J. 2014 May 30; 4(5):e214.
    View PubMed
  60. Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 2014 May 08; 123(19):3007-15. Epub 2014 Feb 04.
    View PubMed
  61. Bailey NG, Elenitoba-Johnson KS. Molecular diagnostics of T-cell lymphoproliferative disorders. Cancer J. 2014 Jan-Feb; 20 (1):48-60
    View PubMed
  62. Chaudhary LN, Bailey NG, Vos JA, Stotler CJ. Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP. W V Med J. 2013 Mar-Apr; 109 (2):6-9
    View PubMed
  63. Bailey N. Aggressive genetic “double-hit” B-cell lymphoma following renal transplantation: case report. . J Hematopathol. 2013.
  64. Stall JN, Bailey NG. Metastatic alveolar rhabdomyosarcoma to the bone marrow mimicking acute leukemia. Blood. 2012 Nov 1; 120 (18):3632
    View PubMed
  65. Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012 Aug 27; 209 (9):1553-65 Epub 2012 Aug 13
    View PubMed
  66. Rellick SL, O'Leary H, Piktel D, Walton C, Fortney JE, Akers SM, Martin KH, Denvir J, Boskovic G, Primerano DA, Vos J, Bailey N, Gencheva M, Gibson LF. Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012; 7 (2):e30758 Epub 2012 Feb 17
    View PubMed
  67. Safder S, Carpenter JS, Roberts TD, Bailey N. The "Black Turbinate" sign: An early MR imaging finding of nasal mucormycosis. AJNR Am J Neuroradiol. 2010 Apr; 31 (4):771-4 Epub 2009 Nov 26
    View PubMed
  68. Bailey NG, South ST, Hummel M, Wenger SL. Case report: cytogenetic and molecular analysis of proximal interstitial deletion of 4p, review of the literature and comparison with wolf-hirschhorn syndrome. J Assoc Genet Technol. 2010; 36 (1):5-10
    View PubMed
  69. Pemberton JD, Vidor I, Sivak-Callcott JA, Bailey NG, Sarwari AR. North American blastomycosis of the eyelid. Ophthalmic Plast Reconstr Surg. 2009 May-Jun; 25 (3):230-2
    View PubMed
  70. Ibrahim WH, Bailey N, Sunvold GD, Bruckner GG. Effects of carnitine and taurine on fatty acid metabolism and lipid accumulation in the liver of cats during weight gain and weight loss. Am J Vet Res. 2003 Oct; 64 (10):1265-77
    View PubMed